Polio Sabin™(oral) vaccine is a stabilised preparation of live attenuated poliomyelitis viruses of the Sabin™ strains type 1, 2 and 3, propagated in MRC5 human diploid cells. Polio Sabin™ (oral) is indicated for active immunisation of infants and susceptible children and adults against infection caused by 3 types of wild Polioviruses.
- The primary immunisation course is three doses of Polio Sabin™ (oral) vaccine
- The vaccine should be administered with an interval of at least one month between doses
Children and adults:
- A booster dose at the time of school entry and occasionally in adult life when a person is likely to be exposed to a high risk of infection, such as when travelling to endemic areas
Polio Sabin™ (oral) is for oral use only. One dose of vaccine (0.1 ml) should be delivered in 2 drops from the polyethylene dropper supplied with the glass vial or directly from the plastic tube.
For Immunization schedule as per IAP guidelines see OPV Immunization schedule
Polio Sabin™ (oral) should not be given to children with known hypersensitivity to neomycin or polymyxin or to any other component of the vaccine. Immunodeficiency is also a contraindication, inactivated polio vaccine (IPV) should be alternatively administered.